InvestorsObserver
Sign Up Login

SPPI Spectrum Pharma Inc

$1.01 $-0.06 (-5.61%)
Add to Watchlist Compare
Overall

SPPI Stock Analysis Overview

What this means: InvestorsObserver gives Spectrum Pharma Inc (SPPI) an overall rank of 35, which is below average. Spectrum Pharma Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

SPPI Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

SPPI Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

SPPI Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

SPPI Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

SPPI Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

SPPI Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

SPPI Stock Analysis Overview

What this means: InvestorsObserver gives Spectrum Pharma Inc (SPPI) an overall rank of 35, which is below average. Spectrum Pharma Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full SPPI report

SPPI Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

SPPI Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

SPPI Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

SPPI Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

SPPI Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

SPPI Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Spectrum Pharma Inc (SPPI) Analyst Forecast

SPPI Price, Volume, Earnings, and Dividend Date

  • Last Price $1.01
  • Previous Close $1.07
  • Change $-0.06
  • Open $1.08
  • Volume 3,823,389
  • Avg. Volume (100-day) 3,948,675
  • Market Cap 165,595,904
  • Days Range 1 - 1.1
  • 52-week Range 1.04 - 4.54
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 02/08/22
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta 2.531
  • PEG Ratio —

Spectrum Pharma Inc (SPPI) Company Description

Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. As an oncology products manufacturer, it develops drugs to combat various kinds of tumors. The SPI-2012 is being developed for chemotherapy-induced neutropenia in patients with breast cancer, and EOQUIN addresses immediate intravesical instillation and post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer.

Spectrum Pharma Inc (SPPI) Stock Chart

View Interactive SPPI chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Biotechnology

Company Price
Opiant Pharmaceuticals Inc (OPNT) (OPNT) $25.22
Adicet Bio Inc (ACET) (ACET) $12.69
Crinetics Pharmaceuticals Inc (CRNX) (CRNX) $20.93
Xenon Pharmaceuticals Inc (XENE) (XENE) $29.12
Zogenix Inc (ZGNX) (ZGNX) $26.00
Genfit S.A. ADR (GNFT) (GNFT) $4.53
Catalyst Pharm Inc (CPRX) (CPRX) $5.69
Tricida Inc (TCDA) (TCDA) $9.00
Iveric Bio Inc (ISEE) (ISEE) $12.54
Regeneron Pharmaceuticals (REGN) (REGN) $614.38